{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T01:46:45Z","timestamp":1778896005764,"version":"3.51.4"},"reference-count":38,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T00:00:00Z","timestamp":1703116800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"German Center for Infection Research (DZIF)","award":["TTU07.815.00"],"award-info":[{"award-number":["TTU07.815.00"]}]},{"name":"German Center for Infection Research (DZIF)","award":["#70114234"],"award-info":[{"award-number":["#70114234"]}]},{"name":"German Center for Infection Research (DZIF)","award":["CMMC\u2014B10"],"award-info":[{"award-number":["CMMC\u2014B10"]}]},{"name":"laboratory is currently supported by funds of the Cancer Research Center Cologne Essen (CCCE), Deutsche Krebshilfe","award":["TTU07.815.00"],"award-info":[{"award-number":["TTU07.815.00"]}]},{"name":"laboratory is currently supported by funds of the Cancer Research Center Cologne Essen (CCCE), Deutsche Krebshilfe","award":["#70114234"],"award-info":[{"award-number":["#70114234"]}]},{"name":"laboratory is currently supported by funds of the Cancer Research Center Cologne Essen (CCCE), Deutsche Krebshilfe","award":["CMMC\u2014B10"],"award-info":[{"award-number":["CMMC\u2014B10"]}]},{"name":"Center for Molecular Medicine Cologne","award":["TTU07.815.00"],"award-info":[{"award-number":["TTU07.815.00"]}]},{"name":"Center for Molecular Medicine Cologne","award":["#70114234"],"award-info":[{"award-number":["#70114234"]}]},{"name":"Center for Molecular Medicine Cologne","award":["CMMC\u2014B10"],"award-info":[{"award-number":["CMMC\u2014B10"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Antiviral neutralizing antibodies (nAbs) are commonly derived from B cells developed in immunized or infected animals and humans. Fully human antibodies are preferred for clinical use as they are potentially less immunogenic. However, the function of B cells varies depending on their homing pattern and an additional hurdle for antibody discovery in humans is the source of human tissues with an immunological microenvironment. Here, we show an efficient method to pharm human antibodies using immortalized B cells recovered from Nod.Rag.Gamma (NRG) mice reconstituting the human immune system (HIS). Humanized HIS mice were immunized either with autologous engineered dendritic cells expressing the human cytomegalovirus gB envelope protein (HCMV-gB) or with Epstein\u2013Barr virus-like particles (EB-VLP). Human B cells recovered from spleen of HIS mice were efficiently immortalized with EBV in vitro. We show that these immortalized B cells secreted human IgGs with neutralization capacities against prototypic HCMV-gB and EBV-gp350. Taken together, we show that HIS mice can be successfully used for the generation and pharming fully human IgGs. This technology can be further explored to generate antibodies against emerging infections for diagnostic or therapeutic purposes.<\/jats:p>","DOI":"10.3390\/cells13010020","type":"journal-article","created":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T03:36:17Z","timestamp":1703129777000},"page":"20","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Fully Human Herpesvirus-Specific Neutralizing IgG Antibodies Generated by EBV Immortalization of Splenocytes-Derived from Immunized Humanized Mice"],"prefix":"10.3390","volume":"13","author":[{"given":"Sebastian J.","family":"Theobald","sequence":"first","affiliation":[{"name":"Department I of Internal Medicine, University Hospital Cologne, Faculty of Medicine, University of Cologne, 50937 Cologne, Germany"},{"name":"Center for Molecular Medicine Cologne (CMMC), University Hospital Cologne, Faculty of Medicine, University of Cologne, 50937 Cologne, Germany"},{"name":"German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, 50931 Cologne, Germany"},{"name":"Clinic of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, 30625 Hannover, Germany"},{"name":"German Center for Infection Research (DZIF), Partner Site Hannover-Braunschweig, 30559 Hannover, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Fiestas","sequence":"additional","affiliation":[{"name":"Research Unit Gene Vectors, Helmholtz Center Munich, German Research Center for Environmental Health, 81377 Munich, Germany"},{"name":"German Center for Infection Research (DZIF), Partner Site Munich, 81377 Munich, Germany"},{"name":"Institute of Structural Biology, Helmholtz Center Munich, German Research Center for Environmental Health, 81377 Munich, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Schneider","sequence":"additional","affiliation":[{"name":"Clinic of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, 30625 Hannover, Germany"},{"name":"German Center for Infection Research (DZIF), Partner Site Hannover-Braunschweig, 30559 Hannover, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Ostermann","sequence":"additional","affiliation":[{"name":"Clinic of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, 30625 Hannover, Germany"},{"name":"German Center for Infection Research (DZIF), Partner Site Hannover-Braunschweig, 30559 Hannover, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Danisch","sequence":"additional","affiliation":[{"name":"Clinic of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, 30625 Hannover, Germany"},{"name":"German Center for Infection Research (DZIF), Partner Site Hannover-Braunschweig, 30559 Hannover, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Constantin","family":"von Kaisenberg","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology and Reproductive Medicine, Hannover Medical School, 30625 Hannover, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8351-2690","authenticated-orcid":false,"given":"Jan","family":"Rybniker","sequence":"additional","affiliation":[{"name":"Department I of Internal Medicine, University Hospital Cologne, Faculty of Medicine, University of Cologne, 50937 Cologne, Germany"},{"name":"Center for Molecular Medicine Cologne (CMMC), University Hospital Cologne, Faculty of Medicine, University of Cologne, 50937 Cologne, Germany"},{"name":"German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, 50931 Cologne, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Hammerschmidt","sequence":"additional","affiliation":[{"name":"Research Unit Gene Vectors, Helmholtz Center Munich, German Research Center for Environmental Health, 81377 Munich, Germany"},{"name":"German Center for Infection Research (DZIF), Partner Site Munich, 81377 Munich, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3357-4954","authenticated-orcid":false,"given":"Reinhard","family":"Zeidler","sequence":"additional","affiliation":[{"name":"German Center for Infection Research (DZIF), Partner Site Munich, 81377 Munich, Germany"},{"name":"Institute of Structural Biology, Helmholtz Center Munich, German Research Center for Environmental Health, 81377 Munich, Germany"},{"name":"Department of Otorhinolaryngology, Munich University Hospital, 81377 Munich, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renata","family":"Stripecke","sequence":"additional","affiliation":[{"name":"Department I of Internal Medicine, University Hospital Cologne, Faculty of Medicine, University of Cologne, 50937 Cologne, Germany"},{"name":"Center for Molecular Medicine Cologne (CMMC), University Hospital Cologne, Faculty of Medicine, University of Cologne, 50937 Cologne, Germany"},{"name":"German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, 50931 Cologne, Germany"},{"name":"Clinic of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, 30625 Hannover, Germany"},{"name":"German Center for Infection Research (DZIF), Partner Site Hannover-Braunschweig, 30559 Hannover, Germany"},{"name":"Institute of Translational Immuno-Oncology, University Hospital Cologne, Faculty of Medicine, University of Cologne, 50937 Cologne, Germany"},{"name":"Cancer Research Center Cologne Essen, University Hospital Cologne, Faculty of Medicine, University of Cologne, 50937 Cologne, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,12,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1056\/NEJMoa2107934","article-title":"Early Treatment for COVID-19 with SARS-CoV-2 Neutralizing Antibody Sotrovimab","volume":"385","author":"Gupta","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jcv.2017.03.005","article-title":"Comparison of cytomegalovirus (CMV)-specific neutralization capacity of hyperimmunoglobulin (HIG) versus standard intravenous immunoglobulin (IVIG) preparations: Impact of CMV IgG normalization","volume":"90","author":"Schampera","year":"2017","journal-title":"J. Clin. Virol."},{"key":"ref_3","first-page":"149","article-title":"Epstein-Barr virus infection and human malignancies","volume":"82","author":"Niedobitek","year":"2001","journal-title":"Int. J. Exp. Pathol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e2034","DOI":"10.1002\/rmv.2034","article-title":"Estimation of the worldwide seroprevalence of cytomegalovirus: A systematic review and meta-analysis","volume":"29","author":"Zuhair","year":"2019","journal-title":"Rev. Med. Virol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/nrc.2016.92","article-title":"Epstein-Barr virus: More than 50 years old and still providing surprises","volume":"16","author":"Young","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Murray, M.J., Peters, N.E., and Reeves, M.B. (2018). Navigating the Host Cell Response during Entry into Sites of Latent Cytomegalovirus Infection. Pathogens, 7.","DOI":"10.3390\/pathogens7010030"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1172\/JCI136225","article-title":"Herpesvirus latency","volume":"130","author":"Cohen","year":"2020","journal-title":"J. Clin. Investig."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"3893","DOI":"10.2147\/IDR.S224291","article-title":"Epidemiology, Outcome and Risk Factors Analysis of Viral Infections in Children and Adolescents Undergoing Hematopoietic Cell Transplantation: Antiviral Drugs Do Not Prevent Epstein-Barr Virus Reactivation","volume":"12","author":"Czyzewski","year":"2019","journal-title":"Infect. Drug Resist."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/cid\/ciu364","article-title":"Donor cytomegalovirus status influences the outcome of allogeneic stem cell transplant: A study by the European group for blood and marrow transplantation","volume":"59","author":"Ljungman","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Stern, L., Withers, B., Avdic, S., Gottlieb, D., Abendroth, A., Blyth, E., and Slobedman, B. (2019). Human Cytomegalovirus Latency and Reactivation in Allogeneic Hematopoietic Stem Cell Transplant Recipients. Front. Microbiol., 10.","DOI":"10.3389\/fmicb.2019.01186"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e02392-16","DOI":"10.1128\/JVI.02392-16","article-title":"Congenital Human Cytomegalovirus Infection and the Enigma of Maternal Immunity","volume":"91","author":"Britt","year":"2017","journal-title":"J. Virol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/infdis\/jit096","article-title":"Primary Epstein-Barr virus infection: Impact of age at acquisition, coinfection, and viral load","volume":"207","author":"Balfour","year":"2013","journal-title":"J. Infect. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nrc1452","article-title":"Epstein-Barr virus: 40 years on","volume":"4","author":"Young","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"4992","DOI":"10.1182\/blood-2008-09-178046","article-title":"Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation","volume":"113","author":"Landgren","year":"2009","journal-title":"Blood"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Theobald, S.J., Kreer, C., Khailaie, S., Bonifacius, A., Eiz-Vesper, B., Figueiredo, C., Mach, M., Backovic, M., Ballmaier, M., and Koenig, J. (2020). Repertoire characterization and validation of gB-specific human IgGs directly cloned from humanized mice vaccinated with dendritic cells and protected against HCMV. PLoS Pathog., 16.","DOI":"10.1371\/journal.ppat.1008560"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Kumar, S., Koenig, J., Schneider, A., Wermeling, F., Boddul, S., Theobald, S.J., Vollmer, M., Kloos, D., Lachmann, N., and Klawonn, F. (2021). In Vivo Lentiviral Gene Delivery of HLA-DR and Vaccination of Humanized Mice for Improving the Human T and B Cell Immune Reconstitution. Biomedicines, 9.","DOI":"10.3390\/biomedicines9080961"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Rancan, C., Schirrmann, L., Huls, C., Zeidler, R., and Moosmann, A. (2015). Latent Membrane Protein LMP2A Impairs Recognition of EBV-Infected Cells by CD8+ T Cells. PLoS Pathog., 11.","DOI":"10.1371\/journal.ppat.1004906"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Wiesner, M., Zentz, C., Mayr, C., Wimmer, R., Hammerschmidt, W., Zeidler, R., and Moosmann, A. (2008). Conditional immortalization of human B cells by CD40 ligation. PLoS ONE, 3.","DOI":"10.1371\/journal.pone.0001464"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.3389\/fimmu.2017.01709","article-title":"Multidimensional Analysis Integrating Human T-Cell Signatures in Lymphatic Tissues with Sex of Humanized Mice for Prediction of Responses after Dendritic Cell Immunization","volume":"8","author":"Volk","year":"2017","journal-title":"Front. Immunol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e03440-20","DOI":"10.1128\/mBio.03440-20","article-title":"Multiple Viral microRNAs Regulate Interferon Release and Signaling Early during Infection with Epstein-Barr Virus","volume":"12","author":"Bouvet","year":"2021","journal-title":"mBio"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"5188","DOI":"10.1073\/pnas.96.9.5188","article-title":"A first-generation packaging cell line for Epstein-Barr virus-derived vectors","volume":"96","author":"Delecluse","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"15036","DOI":"10.1073\/pnas.232381299","article-title":"Glycoprotein gp110 of Epstein-Barr virus determines viral tropism and efficiency of infection","volume":"99","author":"Neuhierl","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1089\/hum.2019.149","article-title":"Adult and Cord Blood-Derived High-Affinity gB-CAR-T Cells Effectively React Against Human Cytomegalovirus Infections","volume":"31","author":"Olbrich","year":"2020","journal-title":"Hum. Gene Ther."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"8245","DOI":"10.1073\/pnas.95.14.8245","article-title":"Propagation and recovery of intact, infectious Epstein-Barr virus from prokaryotic to human cells","volume":"95","author":"Delecluse","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.3389\/fimmu.2018.02734","article-title":"Signatures of T and B Cell Development, Functional Responses and PD-1 Upregulation after HCMV Latent Infections and Reactivations in Nod.Rag.Gamma Mice Humanized with Cord Blood CD34(+) Cells","volume":"9","author":"Theobald","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jviromet.2016.06.008","article-title":"Generation of a Gaussia luciferase-expressing endotheliotropic cytomegalovirus for screening approaches and mutant analyses","volume":"235","author":"Falk","year":"2016","journal-title":"J. Virol. Methods"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1126\/science.1093933","article-title":"Development of a human adaptive immune system in cord blood cell-transplanted mice","volume":"304","author":"Traggiai","year":"2004","journal-title":"Science"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Danner, R., Chaudhari, S.N., Rosenberger, J., Surls, J., Richie, T.L., Brumeanu, T.D., and Casares, S. (2011). Expression of HLA class II molecules in humanized NOD.Rag1KO.IL2RgcKO mice is critical for development and function of human T and B cells. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0019826"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1182\/blood-2016-04-709584","article-title":"A novel humanized mouse model with significant improvement of class-switched, antigen-specific antibody production","volume":"129","author":"Yu","year":"2017","journal-title":"Blood"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/s41592-018-0071-6","article-title":"A human immune system mouse model with robust lymph node development","volume":"15","author":"Li","year":"2018","journal-title":"Nat. Methods"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1080\/21645515.2017.1403703","article-title":"Generation and testing anti-influenza human monoclonal antibodies in a new humanized mouse model (DRAGA: HLA-A2. HLA-DR4. Rag1 KO. IL-2Rgammac KO. NOD)","volume":"14","author":"Mendoza","year":"2018","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"799","DOI":"10.4049\/jimmunol.1801085","article-title":"Human Anti-HIV-1 gp120 Monoclonal Antibodies with Neutralizing Activity Cloned from Humanized Mice Infected with HIV-1","volume":"202","author":"Gawron","year":"2019","journal-title":"J. Immunol."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Becker, P.D., Legrand, N., van Geelen, C.M., Noerder, M., Huntington, N.D., Lim, A., Yasuda, E., Diehl, S.A., Scheeren, F.A., and Ott, M. (2010). Generation of human antigen-specific monoclonal IgM antibodies using vaccinated \u201chuman immune system\u201d mice. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0013137"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/nature14411","article-title":"Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117","volume":"522","author":"Caskey","year":"2015","journal-title":"Nature"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41541-017-0019-3","article-title":"Antibody therapies for the prevention and treatment of viral infections","volume":"2","author":"Salazar","year":"2017","journal-title":"NPJ Vaccines"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.1038\/s41596-021-00554-w","article-title":"Effective high-throughput isolation of fully human antibodies targeting infectious pathogens","volume":"16","author":"Gieselmann","year":"2021","journal-title":"Nat. Protoc."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e02467-19","DOI":"10.1128\/AAC.02467-19","article-title":"Phase 2 Study of Anti-Human Cytomegalovirus Monoclonal Antibodies for Prophylaxis in Hematopoietic Cell Transplantation","volume":"64","author":"Maertens","year":"2020","journal-title":"Antimicrob Agents Chemother."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"100033","DOI":"10.1016\/j.xcrm.2020.100033","article-title":"Neutralizing Antibodies Protect against Oral Transmission of Lymphocryptovirus","volume":"1","author":"Singh","year":"2020","journal-title":"Cell Rep. Med."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/13\/1\/20\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:39:13Z","timestamp":1760132353000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/13\/1\/20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,21]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,1]]}},"alternative-id":["cells13010020"],"URL":"https:\/\/doi.org\/10.3390\/cells13010020","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,21]]}}}